New antibody combo aims to boost lung cancer treatment response
NCT ID NCT07098988
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 4 times
Summary
This study tests whether adding the experimental drug visugromab to standard chemotherapy and immunotherapy can shrink tumors better than standard treatment alone in people with advanced non-squamous lung cancer that has not been treated before. About 107 adults with newly diagnosed stage IV disease will receive either visugromab or a placebo, combined with the usual drugs. The main goal is to see how many patients have their tumors shrink significantly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
"Sf. Nectarie" Oncology Center, Department of Medical Oncology
RECRUITINGCraiova, Dolj, 200542, Romania
-
Cantonal Hospital Saint Gallen, Clinic of Oncology and Hematology
RECRUITINGSankt Gallen, Canton of St. Gallen, 9007, Switzerland
-
Clinica Polisano S.R.L.
RECRUITINGSibiu, 550253, Romania
-
Clinics Essen-Mitte
RECRUITINGEssen, North Rhine-Westphalia, 45136, Germany
-
Duke University Medical Center
RECRUITINGDurham, North Carolina, 27710, United States
-
Evangelical Hospital Bethel, Clinic for Internal Medicine, Hematology/Oncology, Palliative Medicine Johannesstift
RECRUITINGBielefeld, North Rhine-Westphalia, 33611, Germany
-
Foundation Bethanien Moers
RECRUITINGMoers, North Rhine-Westphalia, 47441, Germany
-
Fribourg Cantonal Hospital
RECRUITINGFribourg, Canton of Fribourg, 1708, Switzerland
-
Gral Medical S.R.L. - Oncofort Hospital
RECRUITINGPiteşti, 110283, Romania
-
Großhansdorf Hospital - Clinical Center for Pulmonology and Thoracic Surgery, Department of Thoracic Oncology
RECRUITINGGroßhansdorf, Schleswig-Holstein, 22927, Germany
-
Hospital Quiron Dexeus Barcelona
RECRUITINGBarcelona, Catalonia, 08028, Spain
-
Hospital del Mar
RECRUITINGBarcelona, Catalonia, 08003, Spain
-
Institute of Romagna for Cancer Research " Dino Amadori" - IRCCS IRST
RECRUITINGMeldola, Forli, 47014, Italy
-
Local Health Unit of Romagna - Santa Maria delle Croci Hospital of Ravenna, Onco-Hematology Department
RECRUITINGRavenna, 48121, Italy
-
MD Anderson International Cancer Center Spain
RECRUITINGMadrid, 28033, Spain
-
MED-Polonia, Sp. z o.o. (LLC)
RECRUITINGPoznan, 60-693, Poland
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
-
NYU Longone Health
RECRUITINGNew York, New York, 10016, United States
-
National Cancer Institute Regina Elena, IRCCS
RECRUITINGRome, 00144, Italy
-
National Cancer Institute, IRCCS
RECRUITINGMilan, Milan, 20133, Italy
-
Oncology Reference Center
RECRUITINGAviano, 33081, Italy
-
Regional University Hospital of Malaga
RECRUITINGMálaga, Andalusia, 29010, Spain
-
SC Oncomed SRL, Department of Medical Oncology
RECRUITINGTimișoara, +40 () 727 774 974, Romania
-
START- Rioja
RECRUITINGRioja, La Rioja, 26006, Spain
-
Specialist Hospital in Prabuty Sp. z o.o. (LLC), Department of Pulmonology
RECRUITINGPrabuty, 82-550, Poland
-
Thorax Clinic Heidelberg
RECRUITINGHeidelberg, Baden-Wurttemberg, 69126, Germany
-
USC Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
-
University Clinic of Navarra - Madrid
RECRUITINGMadrid, Madrid, 28027, Spain
-
University Clinic of Navarra - Pamplona
RECRUITINGPamplona, Chartered Community of Navarre, 31008, Spain
-
University Hospital 12 de Octubre
RECRUITINGMadrid, Madrid, 28041, Spain
-
University Hospital Basel
RECRUITINGBasel, Basel, 4031, Switzerland
-
University Hospital Complex of Santiago (CHUS)
RECRUITINGSantiago de Compostela, Galicia, 15706, Spain
-
University Hospital HM Sanchinarro
RECRUITINGMadrid, Madrid, 28050, Spain
-
University Hospital Lucus Augusti (HULA)
RECRUITINGLugo, 27003, Spain
-
University Hospital Marques de Valdecilla (HUMV)
RECRUITINGSantander, Cantabria, 39008, Spain
-
University Hospital Virgen Macarena
RECRUITINGSeville, Andalusia, 41009, Spain
-
University Hospital Virgen del Rocio (HUVR)
RECRUITINGSeville, Andalusia, 41013, Spain
-
University Hospital Würzburg
RECRUITINGWürzburg, Bavaria, 97080, Germany
-
University Hospital of Jaen
RECRUITINGJaén, Andalusia, 23007, Spain
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294-2936, United States
-
Yale Cancer Center
RECRUITINGNew Haven, Connecticut, 06519, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill combo outperform standard therapy for a Hard-to-Treat lung cancer?
- New MET inhibitor DO-2 enters human trials for Hard-to-Treat cancers
- New combo therapy shows promise for hard-to-treat childhood cancers
- New drug cocktail aims to shrink lung tumors in Late-Stage trial
- New drug combo aims to boost bladder cancer remission before surgery
- Epigenetic and immune drugs join forces against tough tumors